| Differential scanning calorimetry: applications in drug development SD Clas, CR Dalton, BC Hancock Pharmaceutical science & technology today 2 (8), 311-320, 1999 | 395 | 1999 |
| Preparation and Solid-State Characterization of Nonstoichiometric Cocrystals of a Phosphodiesterase-IV Inhibitor and l-Tartaric Acid N Variankaval, R Wenslow, J Murry, R Hartman, R Helmy, E Kwong, ... Crystal growth & design 6 (3), 690-700, 2006 | 132 | 2006 |
| The effect of temperature on water vapor sorption by some amorphous pharmaceutical sugars BC Hancock, CR Dalton Pharmaceutical development and technology 4 (1), 125-131, 1999 | 97 | 1999 |
| A pragmatic test of a simple calorimetric method for determining the fragility of some amorphous pharmaceutical materials BC Hancock, CR Dalton, MJ Pikal, SL Shamblin Pharmaceutical research 15, 762-767, 1998 | 84 | 1998 |
| Physicochemical characterization of five glyburide powders: a BCS based approach to predict oral absorption H Wei, C Dalton, M Di Maso, I Kanfer, R Löbenberg European Journal of pharmaceutics and Biopharmaceutics 69 (3), 1046-1056, 2008 | 70 | 2008 |
| Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases M Gallant, C Beaulieu, C Berthelette, J Colucci, MA Crackower, C Dalton, ... Bioorganic & medicinal chemistry letters 21 (1), 288-293, 2011 | 56 | 2011 |
| Processing and storage effects on water vapor sorption by some model pharmaceutical solid dosage formulations CR Dalton, BC Hancock International journal of pharmaceutics 156 (2), 143-151, 1997 | 54 | 1997 |
| Producing amorphous solid dispersions via co-precipitation and spray drying: impact to physicochemical and biopharmaceutical properties AKP Mann, L Schenck, A Koynov, ACF Rumondor, X Jin, M Marota, ... Journal of pharmaceutical sciences 107 (1), 183-191, 2018 | 48 | 2018 |
| Micro-scale measurement of the mechanical properties of compressed pharmaceutical powders. 2: The dynamic moduli of microcrystalline cellulose BC Hancock, CR Dalton, SD Clas International journal of pharmaceutics 228 (1-2), 139-145, 2001 | 27 | 2001 |
| Drug solubility in fatty acids as a formulation design approach for lipid-based formulations: a technical note YC Lee, C Dalton, B Regler, D Harris Drug Development and Industrial Pharmacy 44 (9), 1551-1556, 2018 | 20 | 2018 |
| Detection of a minor amorphous phase in crystalline etoricoxib by dynamic mechanical analysis: comparison with Raman spectroscopy and modulated differential scanning calorimetry SD Clas, K Lalonde, K Khougaz, CR Dalton, R Bilbeisi Journal of pharmaceutical sciences 101 (2), 558-565, 2012 | 17 | 2012 |
| Investigating the hydrate conversion propensity of different etoricoxib lots CR Dalton, SD Clas, J Singh, K Khougaz, R Bilbeisi Journal of pharmaceutical sciences 95 (1), 56-69, 2006 | 17 | 2006 |
| High bulk-density amorphous dispersions to enable direct compression of reduced tablet size amorphous dosage units DS Frank, H Nie, A Chandra, A Coelho, C Dalton, H Dvorak, A Elkhabaz, ... Journal of Pharmaceutical Sciences 112 (8), 2037-2045, 2023 | 11 | 2023 |
| Flexibility in drug product development: a perspective Y Kapoor, RF Meyer, HM Ferguson, D Skomski, P Daublain, GM Troup, ... Molecular Pharmaceutics 18 (7), 2455-2469, 2021 | 11 | 2021 |
| Densifying co-precipitated amorphous dispersions to achieve improved bulk powder properties DS Frank, A Punia, M Fahy, C Dalton, J Rowe, L Schenck Pharmaceutical Research 39 (12), 3197-3208, 2022 | 10 | 2022 |
| Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonyphenyl)-6'-methyl-[2, 3'] bipyridinyl SD Clas, LS Crocker, JA McCauley, I Davies, C Dalton US Patent 6,441,002, 2002 | 9 | 2002 |
| Calorimetry in pharmaceutical research and development SD Clas, CR Dalton, BC Hancock Encyclopedia of pharmaceutical technology. 2nd ed. New York: Marcel Dekker …, 2002 | 8 | 2002 |
| Polymorphic form of montelukast sodium JH Chou, MB Gentzler, JN Michaels, C Bazin, SD Clas, C Dalton, MG Wu US Patent 7,560,559, 2009 | 7 | 2009 |
| Synthesis of 4-[5-substituted or unsubstituted phenyl)-3-substituted-1H-pyrazol-1-yl] benzenesulfonamides P O'shea, RD Tillyer, X Wang, SD Clas, C Dalton US Patent 6,150,534, 2000 | 7 | 2000 |
| Synthesis of 4-[(5-substituted phenyl)-3-substituted-1H-pyrazol-1-yl] benzenesulfonamide P O'shea, X Wang, RD Tillyer, SD Clas, C Dalton US Patent 6,232,472, 2001 | 3 | 2001 |
